CDC updates guidance on retesting children who received recalled blood lead tests
The Centers for Disease Control and Prevention Friday updated its recommendations for clinicians retesting children tested with recalled LeadCare lead test kits. The Food and Drug Administration and Magellan Diagnostics recently expanded their Class 1 recall of the LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests due to a risk for falsely low results.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services July 14 released its calendar year 2026 proposed rule for the physician fee schedule. As required by…
Blog
A new study funded by Patient Rights Advocate adds to the evidence that physician-owned hospitals (POHs) are not comparable to or substitutes for full-service…
Headline
The 6th Circuit Court of Appeals yesterday affirmed a district court’s decision dismissing a lawsuit that sought to turn a hospital’s decision not to hire…
Headline
A recent opinion piece in The Hill promoting physician-owned hospitals gives a misleading and incomplete account of these facilities and the reasons for…
Blog
A recent piece in The Hill promoting physician-owned hospitals gives a misleading and incomplete account of these facilities and the reasons for current…
Headline
The Centers for Medicare & Medicaid Services late today released its calendar year 2022 final rule for the physician fee schedule. The rule cuts the…